Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.

Canada saw an 11% decline in medically important antibiotic sales for food animals since 2018 — but federal policy changes weren't the reason. A new study in the Journal of Antimicrobial Chemotherapy found no significant link between the 2018 regulations and the drop. Researchers say industry initiatives or early behavioral shifts may be the real drivers, though the policies still laid important groundwork for future antimicrobial stewardship.
Canada overhauled its veterinary antibiotic rules in 2018, requiring prescriptions for medically important antibiotics (MIAs) and stripping growth-promotion claims from labels — moves mirrored by the U.S. and other countries to combat antimicrobial resistance (AMR). On the surface, the results looked promising: MIA sales for food-producing animals fell 11% between 2018 and 2023. But a closer look tells a more complicated story.
Researchers from Public Health Ontario analyzed data from Canada's Veterinary Antimicrobial Sales Reporting system and found no statistically significant association between the 2018 policy changes and the sales decline. The drop held across route-specific, antimicrobial class, province-level, and species-level analyses — none pointing to the regulations as the cause. Instead, the researchers suggest industry-led initiatives or behavioral changes that preceded full policy enforcement may have been the real drivers.
Despite the null findings, the authors stress the policies weren't a waste — they set the stage for stronger, evidence-based stewardship efforts going forward.
Key Takeaways:
Why it matters: Understanding what actually works in reducing veterinary antibiotic use is critical to fighting AMR globally. This study highlights the need for rigorous evaluation of policy interventions — not just their implementation.